Your search returned 36 studies. (Get alerts for new studies):
- A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Conditions: Arthritis
Location: Lake Charles, Louisiana
- A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded
Conditions: Major Depressive Disorder
Location: Lake Charles, Louisiana
- Safety and Efficacy of Cariprazine for Mania
Conditions: Bipolar Disorder - Mania
Location: Lake Charles, Louisiana
- Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
Conditions: Plaque Psoriasis
Location: Lake Charles, Louisiana
- Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Sunset, Louisiana
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Lake Charles, Louisiana
- Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Lake Charles, Louisiana
- Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
Conditions: Bipolar - Depression
Location: Lake Charles, Louisiana
- A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Lake Charles, Louisiana
- Tritanium® Primary Acetabular Shell Study
Conditions: Osteoarthritis - Traumatic Arthritis - Avascular Necrosis
Location: Lake Charles, Louisiana
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing E
Conditions: Acute Coronary Syndrome
Location: Lake Charles, Louisiana
- A Long-Term, Open-Label, Study on Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- A Study of RO4917838 in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Eunice, Louisiana
- A Study of RO4917838 in Patients With Acute Exacerbation of Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM2)
Conditions: Bipolar Disorder, Pediatric
Location: Lake Charles, Louisiana
- To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythemat
Conditions: Cutaneous Lupus Erythematosus
Location: Lake Charles, Louisiana
- A Study of LY2140023 in Patients With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Smoking Cessation Study In Healthy Adolescent Smokers
Conditions: Smoking Cessation
Location: Lake Charles, Louisiana
- Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM2)
Conditions: Bipolar Disorder
Location: Lake Charles, Louisiana
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children an
Conditions: Major Depressive Disorder
Location: Lake Charles, Louisiana
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Lake Charles, Louisiana
- Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
Conditions: Acute Schizophrenia
Location: Lake Charles, Louisiana
- Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- PEARL Schizophrenia Maintenance
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Conditions: Asthma
Location: Sunset, Louisiana
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Sunset, Louisiana
- A Physical Dependence Study in Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Conditions: Chronic Gout
Location: Eunice, Louisiana
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Conditions: Asthma
Location: Sunset, Louisiana
- SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Conditions: Generalized Anxiety Disorder (GAD) - Anxiety, Separation - Phobia, Social
Location: Lake Charles, Louisiana
- A Long-Term Study in Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Eunice, Louisiana
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Sunset, Louisiana
- A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
|